Vivek Roy
Central University of Tamil Nadu(IN)Jacksonville College(US)WinnMed(US)Quantitative BioSciences(US)East Orange VA Medical Center(US)Mayo Clinic in Florida(US)Nemours Children's Clinic(US)
Publications by Year
Research Areas
Multiple Myeloma Research and Treatments, Protein Degradation and Inhibitors, Chronic Lymphocytic Leukemia Research, Cancer Treatment and Pharmacology, Hematopoietic Stem Cell Transplantation
Most-Cited Works
- → Nephrectomy Followed by Interferon Alfa-2b Compared with Interferon Alfa-2b Alone for Metastatic Renal-Cell Cancer(2001)1,728 cited
- → Widespread Genetic Heterogeneity in Multiple Myeloma: Implications for Targeted Therapy(2014)994 cited
- → Management of Newly Diagnosed Symptomatic Multiple Myeloma: updated Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) Consensus Guidelines(2009)623 cited
- → Management of Newly Diagnosed Symptomatic Multiple Myeloma: Updated Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) Consensus Guidelines 2013(2013)489 cited
- → Impact of lenalidomide therapy on stem cell mobilization and engraftment post-peripheral blood stem cell transplantation in patients with newly diagnosed myeloma(2007)349 cited
- → Pomalidomide (CC4047) Plus Low-Dose Dexamethasone As Therapy for Relapsed Multiple Myeloma(2009)